Dentsply Sirona (XRAY): are the analysts right?

Dentsply Sirona · Health Care · ref. ETF XLV · 61 calls · price $10.81
What the company does: DENTSPLY SIRONA fabrique équipements dentaires, produits dentaires et consommables médicaux mondialement.
📈 1-year price
$12.19-26.3% over range
Jul 8, 25low $9.64 · high $16.85Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 9 analysts

🎯 Analyst price target on XRAY

High target · 3 analysts$17+57.3%
Median target · 9 analysts$14+29.5%
Low target · 1 analyst$9-16.7%
Current price$10.81

🗳️ The analyst consensus

Analyst breakdown · 9 (6 months)
Strong Buy0%
Buy33%
Hold44%
Sell22%
Strong Sell0%

💰 Dentsply Sirona dividend

2.89%annual yield
That's ~$0.32 per share per year.

✅ Historical analyst reliability on XRAY

Most reliable analysts on XRAY (% profitable · 365j · ≥2 calls)
Needham 0% -27.5% 3
Barrington Research 0% -35.3% 12
UBS 0% -38.2% 2

📊 What $1,000 invested in Dentsply Sirona would be worth

In short — $1,000 invested in Dentsply Sirona 10 years ago would be worth $180 today, i.e. -16%/yr on average. Best year: 2019 (+33%), worst: 2024 (-43%). Price performance, excluding dividends.

If I'd invested $1,000 in Dentsply Sirona

InvestmentWorth todayGain
1 years ago$537-46%
3 years ago$288-71%
5 years ago$198-80%
10 years ago$180-82%
since inception (1987)$18,190+1719%

Return by year (Dentsply Sirona)

YearReturn$1,000 invested at year start
2026 (YTD)-15%$851 (-15%)
2025-37%$537 (-46%)
2024-43%$305 (-69%)
2023-6%$288 (-71%)
2022-31%$199 (-80%)
20210%$198 (-80%)
2020-4%$189 (-81%)
2019+33%$253 (-75%)
2018-31%$174 (-83%)
2017+7%$187 (-81%)
2016-4%$180 (-82%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on XRAY

Barclays
Jun 4, 26
▼ Underweight · 🎯$9
Price at call : $10 — upside -10%
Today : $10.81 — upside -17%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jun 4, 27
UBS
May 8, 26
▲ Buy · 🎯$17
Price at call : $11 — upside +55%
Today : $10.81 — upside +57%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : May 8, 27
Mizuho
May 6, 26
■ Neutral neutral · not a buy · 🎯$14
Price at call : $11.14 — gap to target +26%
Today : $10.81 — gap to target +30%
🎯 on XRAY : no call matured yet · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : May 6, 27
Citigroup
Apr 15, 26
▼ Sell · 🎯$10
Price at call : $12.09 — upside -17%
Today : $10.81 — upside -7%
🎯 on XRAY : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Apr 15, 27
Mizuho
Mar 2, 26
■ Neutral neutral · not a buy · 🎯$16
Price at call : $14.31 — gap to target +12%
Today : $10.81 — gap to target +48%
🎯 on XRAY : no call matured yet · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Mar 2, 27
▲ Outperform · 🎯$17
Price at call : $14.31 — upside +19%
Today : $10.81 — upside +57%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Mar 2, 27
Wells Fargo
Feb 27, 26
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $14.31 — gap to target -9%
Today : $10.81 — gap to target +20%
🎯 on XRAY : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 27, 27
■ In-Line neutral · not a buy · 🎯$15
Price at call : $14.31 — gap to target +5%
Today : $10.81 — gap to target +39%
🎯 on XRAY : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Feb 27, 27
Baird
Feb 27, 26
■ Neutral neutral · not a buy · 🎯$14
Price at call : $14.68 — gap to target -5%
Today : $10.81 — gap to target +30%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Feb 27, 27
▲ Buy · 🎯$17
Price at call : $12.52 — upside +36%
Today : $10.81 — upside +57%
🎯 on XRAY : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Feb 19, 27
UBS
Feb 3, 26
▲ Buy · 🎯$16
Price at call : $12.54 — upside +28%
Today : $10.81 — upside +48%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Feb 3, 27
Mizuho
Jan 20, 26
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.05 — gap to target +16%
Today : $10.81 — gap to target +30%
🎯 on XRAY : no call matured yet · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Jan 20, 27
▲ Outperform · 🎯$14
Price at call : $12.37 — upside +13%
Today : $10.81 — upside +30%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Jan 5, 27
▲ Outperform · 🎯$14
Price at call : $11.43 — upside +22%
Today : $10.81 — upside +30%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Dec 16, 26
Baird
Dec 16, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11.37 — gap to target +6%
Today : $10.81 — gap to target +11%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Dec 16, 26
Barclays
Dec 9, 25
▼ Underweight · 🎯$12
Price at call : $11.65 — upside +3%
Today : $10.81 — upside +11%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 9, 26
▲ Outperform · 🎯$14
Price at call : $11 — upside +27%
Today : $10.81 — upside +30%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Nov 10, 26
JP Morgan
Nov 7, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11 — gap to target +9%
Today : $10.81 — gap to target +11%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Nov 7, 26
Wells Fargo
Nov 7, 25
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11 — gap to target +9%
Today : $10.81 — gap to target +11%
🎯 on XRAY : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Nov 7, 26
■ Market Perform neutral · not a buy
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 47.4% · +30.6% (19 calls)
in progress (365j)
matures : Nov 7, 26
▲ Outperform · 🎯$18
Price at call : $12.86 — upside +40%
Today : $10.81 — upside +67%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Oct 29, 26
UBS
Oct 28, 25
▲ Buy · 🎯$23
Price at call : $12.86 — upside +79%
Today : $10.81 — upside +113%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Oct 28, 26
■ In-Line neutral · not a buy · 🎯$13
Price at call : $12.38 — gap to target +5%
Today : $10.81 — gap to target +20%
🎯 on XRAY : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Oct 8, 26
Needham
Sep 26, 25
■ Hold neutral · not a buy
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Sep 26, 26
UBS
Aug 8, 25
▲ Buy · 🎯$24
Price at call : $12.53 — upside +92%
Today : $10.81 — upside +122%
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Aug 8, 26
▲ Outperform · 🎯$18
Price at call : $12.53 — upside +44%
Today : $10.81 — upside +67%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Aug 8, 26
Wells Fargo
Aug 8, 25
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $12.53 — gap to target +20%
Today : $10.81 — gap to target +39%
🎯 on XRAY : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Aug 8, 26
Stifel
Aug 8, 25
■ Hold neutral · not a buy · 🎯$17
Price at call : $12.53 — gap to target +36%
Today : $10.81 — gap to target +57%
🎯 on XRAY : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Aug 8, 26
▲ Outperform · 🎯$21
Price at call : $16.85 — upside +25%
Today : $10.81 — upside +94%
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
in progress (365j)
matures : Jul 22, 26
Needham
Jul 21, 25
■ Hold neutral · not a buy
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Jul 21, 26
▲ Outperform · 🎯$21
Price at call : $16.75 — upside +25%
Today : $10.81 — upside +94%
Expected +25% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-34.3%
stock -34% · XLV +7%
UBS
May 10, 25
▲ Buy · 🎯$25
Price at call : $16.75 — upside +49%
Today : $10.81 — upside +131%
Expected +49% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
-34.9%
stock -35% · XLV +5%
Piper Sandler
Apr 30, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $13.93 — gap to target +15%
Today : $10.81 — gap to target +48%
🎯 on XRAY : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Apr 30, 26
Mizuho
Mar 13, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $15.56 — gap to target +16%
Today : $10.81 — gap to target +67%
🎯 on XRAY : no call matured yet · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Mar 13, 26
Needham
Mar 13, 25
■ Hold neutral · not a buy
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Mar 13, 26
Wells Fargo
Feb 28, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $15.99 — gap to target +19%
Today : $10.81 — gap to target +76%
🎯 on XRAY : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 28, 26
▲ Outperform · 🎯$20
Price at call : $15.99 — upside +25%
Today : $10.81 — upside +85%
Expected +25% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-10.5%
stock -11% · XLV +6%
Baird
Feb 28, 25
■ Neutral neutral · not a buy · 🎯$20
Price at call : $16.55 — gap to target +21%
Today : $10.81 — gap to target +85%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Feb 28, 26
Needham
Feb 28, 25
▲ Buy · 🎯$23
Price at call : $16.55 — upside +39%
Today : $10.81 — upside +113%
Expected +39% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-13.5%
stock -14% · XLV +6%
Wells Fargo
Feb 14, 25
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.32 — gap to target +9%
Today : $10.81 — gap to target +85%
🎯 on XRAY : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 14, 26
Needham
Feb 11, 25
▲ Buy · 🎯$25
Price at call : $18.37 — upside +36%
Today : $10.81 — upside +131%
Expected +36% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-30.3%
stock -30% · XLV +7%
Needham
Jan 30, 25
▲ Buy · 🎯$25
Price at call : $20.31 — upside +23%
Today : $10.81 — upside +131%
Expected +23% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (3 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-38.6%
stock -39% · XLV +5%
Jefferies
Jan 23, 25
■ Hold neutral · not a buy · 🎯$20
Price at call : $19.44 — gap to target +3%
Today : $10.81 — gap to target +85%
🎯 on XRAY : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Jan 23, 26
■ In-Line neutral · not a buy · 🎯$20
Price at call : $18.61 — gap to target +7%
Today : $10.81 — gap to target +85%
🎯 on XRAY : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Jan 7, 26
▲ Overweight · 🎯$23
Price at call : $18.68 — upside +23%
Today : $10.81 — upside +113%
Expected +23% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
-39.6%
stock -40% · XLV +12%
Mizuho
Dec 4, 24
■ Neutral neutral · not a buy · 🎯$21
Price at call : $19.46 — gap to target +8%
Today : $10.81 — gap to target +94%
🎯 on XRAY : no call matured yet · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Dec 4, 25
UBS
Dec 3, 24
▲ Buy · 🎯$27
Price at call : $19.39 — upside +39%
Today : $10.81 — upside +150%
Expected +39% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
-41.5%
stock -42% · XLV +6%
▲ Outperform · 🎯$24
Price at call : $17.65 — upside +36%
Today : $10.81 — upside +122%
Expected +36% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-37.7%
stock -38% · XLV -1%
Baird
Nov 8, 24
■ Neutral neutral · not a buy · 🎯$24
Price at call : $17.86 — gap to target +34%
Today : $10.81 — gap to target +122%
🎯 on XRAY : no call matured yet · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Nov 8, 25
■ Market Perform neutral · not a buy
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Nov 7, 25
▲ Outperform · 🎯$36
Price at call : $26.17 — upside +38%
Today : $10.81 — upside +233%
Expected +38% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-49.4%
stock -49% · XLV -12%
▲ Outperform · 🎯$38
Price at call : $24.2 — upside +57%
Today : $10.81 — upside +252%
Expected +57% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-31.5%
stock -32% · XLV -7%
▲ Outperform · 🎯$38
Price at call : $28.25 — upside +35%
Today : $10.81 — upside +252%
Expected +35% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-51.0%
stock -51% · XLV -2%
▲ Outperform · 🎯$41
Price at call : $30.5 — upside +34%
Today : $10.81 — upside +279%
Expected +34% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-58.0%
stock -58% · XLV -5%
▲ Outperform · 🎯$41
Price at call : $33.28 — upside +23%
Today : $10.81 — upside +279%
Expected +23% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-51.9%
stock -52% · XLV +2%
▲ Outperform · 🎯$42
Price at call : $33.69 — upside +25%
Today : $10.81 — upside +289%
Expected +25% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)
-44.1%
stock -44% · XLV +1%
William Blair
Nov 10, 23
▲ Outperform
Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (1 call matured) · 📊 on Health : 47.4% · +30.6% (19 calls)
-37.8%
stock -38% · XLV +18%
▲ Outperform · 🎯$41
Price at call : $28.56 — upside +44%
Today : $10.81 — upside +279%
Expected +44% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-18.3%
stock -18% · XLV +14%
▲ Outperform · 🎯$51
Price at call : $39.49 — upside +29%
Today : $10.81 — upside +372%
Expected +29% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-38.0%
stock -38% · XLV +10%
▲ Outperform · 🎯$51
Price at call : $41.3 — upside +23%
Today : $10.81 — upside +372%
Expected +23% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on XRAY : 0% (12 calls matureds) · 📊 on Health : 30.4% · -9.3% (69 calls)
-31.6%
stock -32% · XLV +6%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)